In the second part of our interview with a collection of pharmacists from various backgrounds, they delve into the current developments highlighting the future of the profession.
News|Articles|July 1, 2025
Declining Interest in Community Pharmacy Practice Reflects Career, Industry Uncertainty
Author(s)Ashley Gallagher, MA
Interest in community pharmacy practice is declining as pharmacists seek roles with better work-life balance, greater autonomy, and more meaningful patient care opportunities.
Advertisement
Advertisement
Pharmacists are considered medication experts, and historically, their role in health care revolved around dispensing medication. Oftentimes, pharmacists had little interaction with patients or other health care providers. However, their role has shifted, and they are now essential health care team members who focus on championing affordable care, healthier communities, and better clinical outcomes.1
Related to this article
Phase 2 trial results for the investigational vaccine were presented at IDWeek 2026 in Washington, DC, as the phase 3 program is currently underway.
The finalized rule is another step in the right direction for pharmacies calling for reform due to underwater reimbursement and other PBM pressures.
Allison Schneider, MPH, provides a detailed update regarding pharmacies’ impact within Medicare price negotiations and the legislation further impacting businesses.
The US health department announced policies that will allow for the compounding of 6 key peptides in US pharmacies.
New survey data add to the evidence regarding the safe and effective route of administering both COVID-19 and flu vaccines simultaneously.
This episode breaks down how PBMs conduct inventory audits, the sourcing and timing issues that trigger recoupments, and how pharmacies can prepare and push back.
In part 2 of our discussion with Kimberly Kue-Tsemo, PharmD, she addresses the emergence of technology and the nuances behind its actual capabilities.
Advertisement
Advertisement